Galectin-1 (Gal-1) is a B-galactose-binding lectin; its expression level has been reported to correlate with tumor progression. Gal-1 is highly expressed in the invasive front of primary tumors and in the cancer cells of metastatic lesions in the lymph nodes of patients with oral squamous cell carcinoma. However, the molecular mechanism of Gal-1 in tumor metastasis is not completely clear. We found that increased Gal-1 expression is closely associated with its high levels of invasion in lung adenocarcinoma and oral squamous cell carcinoma cell lines. Knocking down Gal-1 with small interfering RNA in highly invasive cancer cells reduced their invasion levels. Moreover, the invasion ability of poorly invasive cancer cells was significantly increased after Gal-1 overexpression of Gal-1. Mechanism studies revealed that Gal-1 promoted tumor invasion mainly by up-regulating matrix metalloproteinase (MMP)-9 and MMP-2 and by reorganizing actin cytoskeleton. Gal-1 enhanced the activation of Cdc42, a small GTPase and member of the Rho family, thus increasing the number and length of filopodia on tumor cells. Furthermore, Gal-1-overexpressing cells had higher metastatic abilities in tail vein metastasis assays in vivo. We conclude that Gal-1 is involved in tumor invasion and metastasis by increasing MMP expression and reorganizing cytoskeletons in oral cancers and lung adenocarcinoma. (Mol Cancer Res 2009;7(3):311 -8) 
Introduction
Metastasis is a multistep process and the leading cause of death from cancer. During metastatic conversion, cancer cells escape from their original tissue, invade the surrounding tissues of the primary tumor, and penetrate a lymphatic or blood vessel (1) . Some survive in the circulation and reach distal sites. Finally, the survivors extravasate and colonize in the second organ (2) . Increased invasiveness of cancer cells is a critical step in tumor metastasis and many changes are required; for example, cancer cells loosen their adhesion to neighboring cells and the extracellular matrix, degrade adjacent tissues, and elevate their motility (3) . In tumor cells and their microenvironmental cells, genetic or epigenetic changes can alter the expression of many genes, such as matrix metalloproteinases (MMP; refs. 4, 5) , integrins (6) , and cadherins (7, 8) , to promote cancer progression and metastasis. Therefore, understanding the molecular mechanisms of how changes in gene expression affect tumor invasion and metastasis is important for designing therapeutic approaches.
Galectin-1 (Gal-1) is a member of the h-galatoside-binding lectin family and exists as a noncovalent homodimer composed of two carbohydrate recognition domains to recognize a wide range of glycoprotein or glycolipid (9) . Gal-1 acts extracellularly by binding to cell surface receptors and extracellular matrix, such as neuropilin-1 (10), integrins (11) , fibronectin, laminin (12) , and carcinoembryonic antigen (13) . In addition, it exists intracellularly and interacts with cytoplasmic and nuclear proteins to regulate cell transformation (14) or pre-mRNA splicing (15) . Immunohistochemical staining of Gal-1 in clinical cancer samples reveals that its expression is positively associated with the malignant progression of many tumor types, including glioma (16) , prostate (17) , colon (18) , breast (19) , cervical (20) , and oral squamous (21) cells. The expression of Gal-1 in carcinoma-associated stromal cells was significantly correlated with breast tumor invasiveness and lymph node metastasis (19) . The possible mechanisms of how Gal-1 contributes to cancer progression and metastasis have been proposed: it regulates tumor cell growth (22) , triggers the death of infiltrating T cells (23) , suppresses T-cell-derived proinflammatory cytokine secretion (24) , mediates cell-cell or cellextracellular matrix adhesion (12, 25) , is involved in tumor angiogenesis (26) , and promotes cancer cell migration (16, 27) . However, it is still unclear whether Gal-1 affects the invasive ability of oral squamous cell carcinoma (OSCC) and lung adenocarcinoma and their underlying molecular mechanisms.
We recently showed (21) that strong Gal-1 immunoreactivity was present in the cancer cells of metastatic lesions of lymph nodes and in the invasive fronts of primary tumors and was significantly associated with poor prognosis in early-stage OSCC. In the current study, we provide direct functional evidence that Gal-1 affects the ability of tumor invasion and metastasis in lung adenocarcinoma and oral cancer cell lines. Furthermore, the molecular mechanisms underlying Gal-1-enhanced cancer cell invasion were elucidated for understanding the mode of action.
Results

Increased Expression of Gal-1 Is Correlated with Elevated Invasiveness
We used an invasion chamber assay to compare the invasiveness of three OSCC cell lines, HSC-3, OC-2, and OEC-M1. HSC-3 is a highly malignant and invasive OSCC cell line, isolated from metastatic tumors in a lymph node (28), whereas OC-2 and OEC-M1 were established from primary tumors of OSCC patients. We found that HSC-3 cells were 2.6 and 8 times more invasive than OC-2 and OEC-M1 cells, respectively (Fig. 1A) . Western blot analysis of the three cell lines showed that Gal-1 expression was higher in HSC-3 cells than in OEC-M1 and OC-2 cells and that there was no obvious difference in Gal-1 expression between OC-2 and OEC-M1 cells (Fig. 1A, bottom) . To rule out the possibility that the result was due to different genetic backgrounds, Gal-1 expression was also analyzed in several lung adenocarcinoma cell sublines, CL1-1, CL1-5F4, and CL1-5, with different levels of invasiveness (29) . Although Gal-1 was detectable in the two highly invasive sublines (CL1-5F4 and CL1-5), it was almost undetectable in the least invasive cell line (CL1-1; Fig. 1B) . These results showed that Gal-1 expression was correlated with the invasiveness of OSCC and lung adenocarcinoma cell lines. Immunostaining four pairs of OSCC tissue also revealed that Gal-1 was strongly immunoreactive in metastatic lesions in lymph nodes (Fig. 1C , right) but weakly immunoreactive in primary tumor sites (Fig. 1C, left) , which is consistent with our previous finding (21) that Gal-1 expression in primary OSCC tumors with regional lymph node metastasis was significantly higher than in those without regional lymph node metastasis, which suggested that Gal-1 expression is associated with tumor invasion and metastasis.
The expression of different members in the galectin family is associated with cancer progression (30) . Galectin-3 (Gal-3) expression is either positively correlated with cancer progression, as in gastric (31) and thyroid (32) cancers, or negatively associated with tumor metastasis, as in breast (33) and prostate (34) cancers. Although increased Gal-3 expression is associated with reduced disease-free survival in persons with tongue cancers (35) , the effects of Gal-3 on tumor invasiveness are still unclear. To compare the roles of Gal-1 and Gal-3 in oral cancer invasion and metastasis, we immunohistochemically analyzed their expression in three pairs of matched primary oral tumor and lymph node metastases. All three tissue pairs showed stronger Gal-1 staining in the cancer cells of metastatic lesions in lymph nodes than in those of the primary tumor ( Supplementary Fig. S1A and B) . However, two of three tissue pairs showed that Gal-3 expression was lower in the lymph nodes than in the primary sites ( Supplementary Fig. S1C and D). The other pair showed no difference in the intensity of the immunostaining of Gal-3. Western blot analysis of the three oral cancer cell lines showed that, although the expression of Gal-3 was high in the least invasive cell line, OEC-M1, there was no apparent difference in Gal-3 expression between OC-2 and HSC-3 cells (Supplementary Fig. S1E ). Taken together, these findings suggest that the influence of Gal-3 on OSCC invasion and metastasis may be relatively minor and that Gal-1 mediates oral cancer invasion and metastasis.
Gal-1 Modulated Tumor Cell Invasiveness
To determine whether Gal-1 increased tumor invasion, highly invasive cancer cells, CL1-5 and HSC-3, were treated with three different Gal-1 small interfering RNAs (Gal-1/ siRNA) and then evaluated for tumor invasion. Gal-1 expression in CL1-5 and HSC-3 was reduced after transfection with Gal-1/siRNA ( Fig. 2A and B, top). Of the three Gal-1/ siRNAs, siRNA1 and siRNA2 were the most effective in HSC-3 and CL1-5 cells, respectively. Decreased Gal-1 expression reduced the invasiveness of CL1-5 and HSC-3 cells by f50% ( Fig. 2A and B, bottom) . The results suggested that down-regulating Gal-1 expression may reduce tumor cell invasion.
To further confirm the relationship between Gal-1 and invasiveness, we transduced, in a lentivirus vector, Gal-1 and a green fluorescence protein (GFP) gene into poorly invasive cancer cell lines OEC-M1 and OC-2, respectively. Compared with the OC-2 cells transduced with GFP (OC-2/GFP), the OC-2 cells transduced with Gal-1 (OC-2/Gal-1) showed significantly increased Gal-1 expression (Fig. 2C, top) as well as cancer cell invasiveness (Fig. 2C, bottom) . Notably, although Gal-1 expression was only 50% higher in OEC-M1/ Gal-1 cells compared with OEC-M1/GFP (Fig. 2D, top) , their invasiveness also significantly increased (Fig. 2D, bottom) . Taken together, these results showed that Gal-1 expression levels were positively associated with the invasiveness of cancer cells.
Gal-1 Induced MMP-2 and MMP-9 Gene Expression and Enzymatic Activities
MMPs are a family of zinc-dependent enzymes that degrade extracellular matrix, such as gelatin and collagens. The gelatinases (MMP-2 and MMP-9) are associated with tumor metastasis and progression (4, 36) . For example, MMP-2 and MMP-9 were highly expressed in OSCC patients with lymph node metastasis, and MMP-9 expression was related to poor survival rates of OSCC patients without regional metastasis (37) . Therefore, we used reverse transcription-PCR and gelatin zymography to further examine whether Gal-1 affects MMP-2 and MMP-9 expression and enzymatic activity. Gal-1 overexpression in OC-2 cells elevated the mRNA expression and gelatinolytic activity of both MMP-2 and MMP-9 ( Fig. 3A and B) , but inhibiting Gal-1 reduced them (Fig. 3C) . Furthermore, treating OC-2 cells with MMP inhibitor significantly reduced Gal-1 cell invasiveness (Fig. 3D ). This showed that Gal-1 promoted tumor invasion in part by augmenting MMP-2 and MMP-9 expression and enzymatic activities.
Gal-1 Induced Actin Cytoskeleton Rearrangement
Increased cell motility is a key step in cancer invasion and metastasis; actin cytoskeleton remodeling is an important mechanism of altering cell motility. Changes in the actin cytoskeleton structure, such as increased filopodia formation, promote cancer cell migration and invasiveness (38) . To determine whether Gal-1 affects actin cytoskeleton reorganization, cells were stained with rhodamine-conjugated phalloidin to visualize F-actin distributions. OC-2/Gal-1 cells showed not only an increase in the number of filopodia bundles but also a reduction in protrusive lamellipodia structures compared with OC-2/GFP cells (Fig. 4A) . In contrast to Gal-1-overexpressing cells, si-Gal-1-treated cells (HSC-3/si-Gal-1) had markedly fewer and shorter filopodia (Fig. 4B) . Compared with control cells, the filopodia were, on average, 45% longer (n = 15; P < 0.001, paired t test) in OC-2/Gal-1 cells and 44% shorter in HSC-3/si-Gal-1 cells (n = 15; P < 0.001; Fig. 4C ). Filopodia density was 60% higher (n = 15; P < 0.01) in OC-2/Gal-1 cells and 18% lower (n = 15; P < 0.05) in HSC-3/si-Gal-1 cells (Fig. 4D) . Taken together, these findings showed that Gal-1 strongly affected actin filament localization. Gal-1 expression modulated filopodia formation and increased tumor cell adhesion, migration, and invasiveness.
Gal-1 Regulates Rho Family Small GTPase Activity
The Rho family of small GTPases, Cdc42, Rac1, and RhoA, is a critical regulator of actin cytoskeleton dynamics. Activated Cdc42 and Rac1 induce actin polymerization to extend the cell membrane in finger-like structures, known as filopodia, and in sheet-like structures, known as lamellipodia (39) . RhoA activation triggers the formation of both stress fiber and focal adhesion complex with integrins and associated proteins. In addition, Rho family activity affects the invasiveness of different kinds of tumor cells (38, 40) . We hypothesized that Gal-1 regulates the activities of Rho family GTPases to increase cell motility, filopodia formation, and invasiveness. GTP-bound Rho, Rac, and Cdc42 were affinity purified from cell lysates using a glutathione S-transferase fusion construct of the Rho-binding domain of rhotekin and the p21-binding domain of the target PAK1. We found that Cdc42 activity was significantly increased in OC-2/Gal-1 cells and decreased in HSC-3/ si-Gal-1 cells (Fig. 4E) , which showed that increased Cdc42 activity was involved in the Gal-1-induced actin cytoskeleton rearrangement and increased tumor invasiveness.
Gal-1 Overexpression Increased Oral Cancer Cell Lung Metastasis In vivo
Using an experimental metastasis assay, we next investigated whether Gal-1 increases tumor metastasis in vivo. OC-2/GFP or OC-2/Gal-1 cells (10 6 ) were intravenously injected into severe combined immunodeficient mice in each experimental group (n = 15). The number of lung metastatic nodules in individual mice was counted, under a dissection microscope, 35 days post-treatment. Elevated Gal-1 expression in OC-2 cells significantly increased pulmonary metastatic nodule development (Fig. 5A ). Mice injected with OC-2/Gal-1 cells developed 2.3 times as many pulmonary metastatic nodules as mice injected with OC-2/GFP cells did (Fig. 5B) .
Discussion
Aberrant gene expression changes or gene mutations in tumor cells or carcinoma-associated stromal cells increases their malignancy and accelerates cancer progression. We found that endogenous Gal-1 expression in OSCC and lung adenocarcinoma cell lines correlated with their levels of invasion. More importantly, Gal-1 overexpression in low metastatic cancer cells enables them to invade and metastasize in vitro and in vivo. Conversely, abrogating Gal-1 expression in highly invasive cancer cells decreases their levels of invasion. Our findings suggest that Gal-1 expression increases as cancer cells progress toward a more malignant phenotype and that Gal-1 expression levels affect the invasiveness of cancer cells. Gal-1 expression in glioblastoma was preferentially higher in more invasive parts of a xenograft, which suggests that Gal-1 expression is closely associated with cancer cell invasiveness (27) . In addition, Gal-1 expression in cancer cells is a prognosis marker of glioma (16) and oral squamous carcinoma (21) , which further supports the hypothesis that Gal-1 is pivotal in tumor invasion and metastasis.
A change in the proteolytic degradation of adjacent tissue is required during tumor invasion. MMP-2 and MMP-9 are major contributors to the degradation of gelatin and collagen extracellular matrix (4). Besides, MMP-2 and MMP-9 expression levels are correlated with lymph node metastasis and poor outcome in head and neck cancer patients (41, 42) and directly affect tumor invasiveness and metastasis (43) . Galectin-7 promotes T-cell lymphoma progression through extracellular stimulation of MMP-9 transcription (44, 45) . We showed that Gal-1 expression was involved in regulating the production and activities of MMP-2 and MMP-9 in OSCC cells and that Gal-1-induced increases in the expression of these MMPs may be one major factor that causes oral cancer cells to become highly invasive and metastatic. It is not clear how Gal-1 regulates MMPs. Investigations of the detailed mechanisms of Gal-1-induced MMP-2 and MMP-9 production and activities are necessary.
Rho family small GTPases, Rho, Rac, and Cdc42, have long been recognized as important modulators of actin cytoskeleton dynamics. When tumors invade the surrounding tissue, the morphologic characteristics and motility of the invading cancer cells must change. We found that Gal-1 overexpression in cancer cells increased the frequency and length of filopodia, which may be related to elevated Cdc42 activity. Cdc42 is the major contributor to filopodia actin structure, and the activation of Cdc42 promotes cancer cell migration and invasion (39, 46) . However, it is unclear how Gal-1 modulates Cdc42 activity. Extracellular Gal-1 stimulation increases glioblastoma cell motility by modifying actin cytoskeleton and up-regulating Rho A expression, but its effect on Rho A activity has not been examined, and we found no significant increase in the expression of Rho family small GTPases (27) . Our findings on the modulation of Cdc42 activity and actin cytoskeleton reorganization highlight the role of Gal-1 as an upstream regulator of the Rho family GTPase activity that promotes tumor invasion and metastasis. Endogenous Gal-1 expression E. Analysis of the activation and expression of Rho family small GTPases by Rho family pull-down assay and Western blotting. Rho family small GTPases pull-down assay was described in Materials and Methods. Intensities of band were quantified by densitometry using GeneTools (Syngene). Fold change was the intensity of the bands corresponding to GTP-Rho family proteins in treated samples (OC-2/Gal-1 or HSC-3/si-Gal-1) normalized to the respective total Rho family protein levels and relative to the control samples (OC-2/GFP or HSC-3/si-C).
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level is positively correlated with the migratory and invasive abilities of glioblastoma cells (47) . Interestingly, knocking down Gal-1 yielded rounder shapes and less lamellipodia formation than in control cells, which was contradictory to our results. Therefore, the effects of Gal-1 on actin cytoskeleton change may be highly dependent on cell type. These contradictory findings also suggest that there may be other mechanisms involved, for example, a change in the phosphorylation of ezrin, a member of the ezrin, radixin, and moesin family, which modulates filopodia formation and induce metastasis (48) .
We conclude that Gal-1 increases tumor invasion levels and may promote cancer metastasis. Gal-1-increased tumor invasion is related to the reorganization of actin cytoskeleton and the upregulation of MMP expression. We showed that Gal-1 increased tumor invasion levels and delineated the Gal-1-induced mechanisms in OSCC and lung adenocarcinoma. Gal-1 is not only a prognosis marker but also a therapeutic target. Fully understanding the role of Gal-1 in tumor invasion opens new avenues for developing therapeutic approaches to inhibit tumor metastasis.
Materials and Methods
Cell Culture
OC-2 and OEC-M1, two oral cell lines established from primary tumors from adult male OSCC patients from Taiwan with a history of betel quid chewing (49, 50) , were grown in RPMI 1640. HSC-3 derived from human tongue carcinoma with lymph node metastasis was from the Japanese Collection of Research Bioresources Cell Bank of Japan was grown in MEM. CL1-0 and CL1-5 human lung cancer cells (29) were cultured in RPMI 1640. All culture media were supplemented with 10% fetal bovine serum, 2 mmol/L L-glutamine, and antibiotics at 37jC in a humidified 5% CO 2 atmosphere.
Immunohistochemical Staining
OSCC tissues were obtained from National Cheng Kung University Hospital. Serial 5 Am histologic sections were deparaffinized in xylene and rehydrated. After blocking of endogenous peroxidase by incubation with 3% hydrogen peroxide, the slides were incubated with the anti-Gal-1 antiserum (1:3,000) overnight at 4jC. The expression of Gal-1 was detected by applying streptavidin-biotin-peroxidase complex (DAKO) and peroxidase activity was revealed by 3-amino-9-ethyl-carbazole. The slides were counterstained with hematoxylin (Invitrogen) and mounted with mounting solution (Invitrogen).
Cell Invasion Assay
Cell invasion assay was done on 24-well Transwells (Costar) with Matrigel-coated polycarbonate filters (8 Am pore size) as described previously (29) . Cancer cells (1 Â 10 5 -2 Â 10 5 ) were plated in the upper chamber well and incubated at 37jC for 24 h. Nonpenetrating cells are removed from the upper surface of the filter with a cotton swab. Penetrating cells were fixed and stained with a DiffQuick stain kit (International Reagents) according to the manufacturer's instructions. For quantification, the assays were done triplicates and all of the cells invaded into the lower surface were stained and counted under a light microscope.
siRNA Transfection
Gal-1 expression was silenced by transfection of siRNA with RNAiFect transfection reagent (Qiagen). Gal-1 siRNAs were synthesized by Invitrogen. AllStar Negative Control siRNA were from Qiagen. The sequences were 5 ¶-UGAUGCACAC-CUCUGCAACACUUCC (Gal-1 siRNA1), 5 ¶-CACUCUC-CAGGUUUGAGAUUCAGGU (Gal-1 siRNA2), and 5 ¶-UUGCUGUUGCACACGAUGGUGUUGG (Gal-1 siRNA3).
Reverse Transcription-PCR
Total RNA was isolated using Trizol reagent (Invitrogen). Total RNA (1 Ag) was reverse transcribed by using IMProm-II Reverse Transcriptase (Promega). The following primers were used: MMP-9 forward 5 ¶-CAACATCACCTATTGGATCC-3 ¶ and reverse 5 ¶-CGGGTGTAGAGTCTCTCGCT-3 ¶, MMP-2 forward 5 ¶-GTGCTGAAGGACACACTAAAGAAGA-3 ¶ and reverse 5 ¶-TTGCCATCCTTCTCAAAGTTGTAGG-3 ¶, and hactin forward 5 ¶-AGCGGGAAATGGTGCGTG-3 ¶ and reverse 5 ¶-CAGGGTACATGGTGGTGGTGCC-3 ¶. All PCRs included h-actin primers to quantify PCR products.
Production of Lentivirus
The sequence encoding human Gal-1 was cloned into pWPXL replacing the GFP marker. All recombinant lentiviruses were produced by transient transfection of 293T cells according to standard protocols (51) . Briefly, subconfluent 293T cells were cotransfected with 20 Ag of a plasmid vector, Comparison of mean lung metastasis count for each group with SD. *, P = 0.0052, two-sided t test.
15 Ag psPAX2, and 5 Ag pMD2.G by calcium phosphate precipitation. After 16 h, medium was changed, and recombinant lentivirus vectors were harvested 48 h later and filtered through 0.45 Am filters. Virus titers were calculated at 72 h after virus infection by counting the number of GFP-expressing foci divided by the dilution factor. For virus infection, culture cells were incubated with culture medium-diluted virus supernatant supplemented with polybrene (8 Ag/mL) for 6 h. To achieve >95% infection efficiency, virus titers of 20 to 40 transduction unit/cells were used.
Immunofluorescence Staining
Immunofluorescence staining for F-actin was done as described previously (40) . Briefly, cells were seeded on the cover slide coated with poly-L-lysine and incubated for 24 h. Cells were washed twice with PBS and fixed in 3.7% paraformaldehyde for 20 min on ice. After washing three times with PBS, cells were permeabilized in 0.05% Triton X-100 for 5 min on ice, washed with PBS, and incubated with rhodamineconjugated phalloidin for 30 min at room temperature. Following another wash with PBS, the cells were examined by confocal fluorescence microscopy.
Filopodia Measurements
To determine the number of filopodia, all filopodial extensions >2 Am were counted on 15 individual cells, and the average F SD per cell was calculated. To calculate the average filopodial length, the distance from the cell base to the tip was determined for all filopodia (>2 Am) of 15 individual cells in each sample, and the average F SD was calculated per filopodium.
Rho Family Small GTPases Pull-Down Assay
The Rho family small GTPases pull-down assay was done as described previously (40) . Briefly, OC-2 cells were lysed in 50 mmol/L Tris-HCl (pH 7.2), 500 mmol/L NaCl, 1% (v/v) Triton X-100, 5 mmol/L MgCl 2 , 1 mmol/L DTT, and protease inhibitors and mixed with bacterially expressed glutathione Stransferase fusing Rho-binding protein, for RhoA-GTP, and glutathione S-transferase PAK3 p21-binding domain, for Rac1-GTP and Cdc42-GTP, and then bound to glutathione Sepharose at 4jC for 30 min. Beads were collected by centrifugation and prepared for Western blotting analysis with anti-RhoA, antiRac1, and anti-Cdc42 antibodies.
Experimental Metastasis In vivo
Cells were washed and resuspended in PBS. Subsequently, a single-cell suspension containing 10 6 cells in 0.1 mL PBS was injected into the lateral tail vein of 6-week-old severe combined immunodeficient mice. Mice were killed after 5 weeks. Lung was examined for metastasis formation. The lungs were removed, weighed, and fixed in 10% formalin. The number of lung tumor colonies was counted under a dissecting microscope. All animal experiments were done in accordance with the animal guidelines at the National Cheng Kung University Laboratory Animal Center.
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